跳至主要内容
临床试验/NCT03809962
NCT03809962已完成不适用

Efficacy and Safety of Ostenil® Plus in the Treatment of Coxarthrosis

TRB Chemedica AG7 个研究点 分布在 1 个国家目标入组 170 人开始时间: 2019年2月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
170
试验地点
7
主要终点
Change of Subjective Symptom Evaluation (Overall Impression on a scale from 1 to 5)

研究概览

简要总结

PMCF study to observe the Routine application of Ostenil® Plus in the Treatment of pain and restricted mobility in degenerative and traumatic changes of the Hip Joint.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
18 Years 至 99 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects ≥ 18 years of age and in good general health condition
  • Signed informed consent
  • Existing Ostenil® Plus recommendation for the treatment of coxarthrosis

排除标准

  • Known hypersensitivity to one of the OSTENIL® PLUS components
  • Known pregnancy or lactating females
  • Previous/concomitant participation in clinical investigation within the last 3 months prior to study inclusion
  • Subjects not capable of contracting and of understanding the nature, risks, significance and implications of the clinical investigation and unable to form a rational intention in the light of these facts
  • Subjects unable to understand informed consent or having a high probability of non compliance to the study procedures and / or non completion of the study according to investigator's judgement (e.g. illiteracy, insufficient knowledge of local language)

结局指标

主要结局

Change of Subjective Symptom Evaluation (Overall Impression on a scale from 1 to 5)

时间窗: Day 7, Day 14, Day 84 after last injection, Day 168 after last injection

The Change of Overall Subjective Symptom Evaluation on a scale from 1 (much improved) to 5 (much worse).

Change of Subjective Therapy Evaluation of Stiffness (HOOS Questionnaire) compared to Baseline

时间窗: Day 84 after last injection, Day 168 after last injection

Hip Disability and Osteoarthritis Outcome Score (HOOS) to assess Stiffness on a 5-point Likert scale

Change of Subjective Therapy Evaluation of Quality of Life (HOOS Questionnaire) compared to Baseline

时间窗: Day 84 after last injection, Day 168 after last injection

Hip Disability and Osteoarthritis Outcome Score (HOOS) to assess Quality of Life on a 5-point Likert scale

Change of Pain Intensity compared to Baseline (VAS-slider)

时间窗: Day 7, Day 14, Day 84 after last injection, Day 168 after last injection

Evaluation of Pain Intensity by the Patient on a 10 cm VAS-slider (10 cm equals the most pain)

Change of Subjective Therapy Evaluation of Pain (HOOS Questionnaire) compared to Baseline

时间窗: Day 84 after last injection, Day 168 after last injection

Hip Disability and Osteoarthritis Outcome Score (HOOS) to assess Pain on a 5-point Likert scale

Change of Range of Motion compared to Baseline (Goniometer measurement)

时间窗: Day 7, Day 14, Day 84 after last injection, Day 168 after last injection

Assessment of the Range of internal and exernal rotation of the Hip Joint using a Goniometer.

Incidence of Treatment-Emergent Adverse Events

时间窗: Up to Day 252 after the last injection

Change of Subjective Therapy Evaluation of Function in daily living (HOOS Questionnaire) compared to Baseline

时间窗: Day 84 after last injection, Day 168 after last injection

Hip Disability and Osteoarthritis Outcome Score (HOOS) to assess Function in daily living on a 5-point Likert scale

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (7)

Loading locations...

相似试验